Modifying CAR T-cells to kill solid tumours
New company created to tackle paediatric cerebral palsy
Strategic partnership to advance space-based life sciences research infrastructure
HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug
New nanoparticles offer safer, more effective drug delivery
Two key proteins perform powerful functions on a major secretory pathway
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
FDA Fast Track Designation for gel to treat calciphylaxis ulcers
Exobiosphere and Space Cargo Unlimited unite for high-throughput biotech in space
Saudi Arabia looks to global biotech collaboration
Targeting NK cells may mean more effective immunotherapy in resistant tumours